Fisher Funds Management LTD

Position in ABT — Abbott Laboratories

CIK 1435028 AUCKLAND, Q2

Position in ABT

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$5,383,241

-$707,759 QoQ

Shares Held

59,326

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#673

of 2,959 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fisher Funds Management LTD holds $144,868,330 across 5 Medical Devices names. ABT ranks #4 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc	840,950	$56,637,982
2	BSX	Boston Scientific Corp	1,007,864	$43,015,635
3	EW	Edwards Lifesciences Corp	397,646	$35,971,057
4	ABT	Abbott Laboratories This page	59,326	$5,383,241
5	MDT	Medtronic plc	49,347	$3,860,415

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,383,241	59,326	0.0%	Shares	Sole	2026-07-14
2026-03-31	$6,091,000	59,326	-15.3%	Shares	Sole	2026-04-16
2025-12-31	$8,774,685	70,035	0.0%	Shares	Sole	2026-01-26
2025-09-30	$9,380,487	70,035	0.0%	Shares	Sole	2025-10-29
2025-06-30	$9,525,460	70,035	-10.0%	Shares	Sole	2025-08-04
2025-03-31	$10,322,292	77,816	0.0%	Shares	Sole	2025-04-29
2024-12-31	$8,801,767	77,816	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.